Evidence map›Paper›PMID 42037259›Full record

ArticleAllergy2026

Definition of Competencies for Allergology Specialty/Subspecialty Training in Mast Cell Disorders in Europe: An EAACI Position Paper.

Tiago Azenha Rama, Theo Gulen, Knut Brockow, Patrizia Bonadonna, Vito Sabato, Clive E Grattan, Sigurd Broesby-Olsen, Sabine Altrichter, Frank Siebenhaar, Jolanta Walusiak-Skorupa and 1 more

Abstract readConsensus Statement
In one paragraph

Article in Allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tiago Azenha RamaServiço de Imunoalergologia, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal.ORCID https://orcid.org/0000-0003-0134-617X
Theo GulenDepartment of Respiratory Medicine and Allergy, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
Knut BrockowDepartment of Dermatology and Allergy Biederstein, School of Medicine and Health, TUM University Hospital Rechts der Isar, Munich, Germany.
Patrizia BonadonnaAllergy Unit, University Hospital, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Vito SabatoImmunology Allergology Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.ORCID https://orcid.org/0000-0002-1321-314X
Clive E GrattanSt John's Institute of Dermatology, London, UK.
Sigurd Broesby-OlsenMastocytosis Centre, Odense University Hospital (MastOUH), Odense University Hospital, Odense, Denmark.
Sabine AltrichterDepartment of Dermatology and Venerology, Kepler University Hospital, Linz, Austria.ORCID https://orcid.org/0000-0001-9955-385X
Frank SiebenhaarInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-4532-1644
Jolanta Walusiak-SkorupaDepartment of Occupational Diseases and Environmental Health, Nofer Institute of Occupational Medicine, Łódź, Poland.
David González-de-OlanoDepartment of Allergy, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.ORCID https://orcid.org/0000-0001-6653-4900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cell disorders (MCD), including mastocytosis and mast cell (MC) activation syndrome (MCAS), encompass a heterogeneous spectrum of diseases often presenting with debilitating manifestations. Variable clinical manifestations, ranging from otherwise asymptomatic cutaneous forms to recurrent anaphylaxis, pose significant challenges for timely diagnosis and effective management. Despite increasing recognition of MCD in Europe, diagnosis is frequently delayed, and therapeutic approaches remain inconsistent, potentially due to gaps and disparities in training. An European Academy of Allergy and Clinical Immunology (EAACI) Task Force (TF) was created to address this need. Through iterative consensus, the TF members formulated ten expert-based recommendations outlining the minimum competencies that allergology and clinical immunology trainees should acquire regarding MCD. These include fundamental knowledge of MC biology, pathogenesis of clonality, recognition of systemic manifestations, diagnostic methodologies, pharmacological and preventive strategies, management of comorbid Hymenoptera venom allergy, pediatric aspects, communication skills, and how to acquire and consolidate expertise. This position paper underscores the need for harmonized competency-based training competencies on MCD for Allergists and Clinical Immunologists across Europe. We advocate for the incorporation of these recommendations into national postgraduate curricula, aiming to foster earlier recognition, improve management, and ultimately enhance long-term outcomes for MCD patients.

Indexed as

Allergy and ImmunologyClinical CompetenceMastocytosisEuropeHumansMast Cellscompetencieseducationmast cell activation syndromemast cell disordersmastocytosis

Identifiers

PMID42037259
PMCPMC13465975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.